Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

Table 29: Gastrointestinal Disorder Therapeutics Market, Europe, Revenue ($bn), 2001-2009 30

Table 30: Gastrointestinal Disorder Therapeutics Market, Europe, Revenue ($bn), 2009-2016 30

Table 31: Gastrointestinal Disorder Therapeutics Market, Europe, Annual Cost of Treatment, 2001-2009 31

Table 32: Gastrointestinal Disorder Therapeutics Market, Europe, Annual Cost of Treatment, 2009-2016 31

Table 33: Gastrointestinal Disorder Therapeutics Market, Europe, Diseased Population, 2001-2009 32

Table 34: Gastrointestinal Disorder Therapeutics Market, Europe, Diseased Population, 2009-2016 32

Table 35: Gastrointestinal Disorder Therapeutics Market, Europe, Treatment Seeking Population, 2001-2009 33

Table 36: Gastrointestinal Disorder Therapeutics Market, Europe, Treatment Seeking Population, 2009-2016 33

Table 37: Gastrointestinal Disorder Therapeutics Market, Europe, Diagnosis Population, 2001-2009 34

Table 38: Gastrointestinal Disorder Therapeutics Market, Europe, Diagnosis Population, 2009-2016 34

Table 39: Gastrointestinal Disorder Therapeutics Market, Europe, Prescription Population, 2001-2009 35

Table 40: Gastrointestinal Disorder Therapeutics Market, Europe'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... 2014 Three Lawrence Livermore researchers ... Hydrogen Production R&D Award for their research ... using sunlight. , Shared with collaborators from the ... of Nevada, Las Vegas (UNLV), the award recognizes ... photoelectrochemical solar-hydrogen production and corrosion processes. , These ...
(Date:8/29/2014)... 2014 A major challenge before new ... dense realm of Boston-Cambridge, is gaining visibility that can ... Sherley, the Director of Boston’s Adult Stem Cell Technology ... national visibility of his company an important priority since ... addition to a social media marketing campaign ...
(Date:8/28/2014)... SAN DIEGO, California, USA (PRWEB) August 28, 2014 ... at the Department of Physics and Optical Science and ... at the University of North Carolina at Charlotte, and ... has been elected to serve as the 2015 Vice ... photonics. , SPIE 2014 President Philip Stahl announced recent ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... ... specifically established to treat adolescents and adults and is today the largest of its kind ... , ... The Hertz Family Foundation of Santa Monica has announced that total contributions now exceed $2 ...
... , Opinion ... , WASHINGTON, Dec. 9 On Tuesday, December 8, 2009, ... The Decade-2 Education Forum in Washington, ... to America,s students and was sponsored by Amgen , a leading biotechnology ...
... Tenn., Dec. 9 Cumberland Pharmaceuticals Inc. (Nasdaq: ... agreement with DB Pharm Korea Co. Ltd. , a Korean-based ... in South Korea. Designed to treat pain and fever in the ... Administration and launched by Cumberland in the United States earlier this ...
Cached Biology Technology:Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
(Date:8/28/2014)... is now available from the Lady Bird Johnson Wildflower ... identifying harmful non-native plant, insect and other invasive species ... cause about $137 billion in economic and other damage ... native plants and more. , "By having streamlined tools ... species occur, we,re more likely to catch these threats ...
(Date:8/28/2014)... your neighbors than traditional cigarettes, but still release ... study from USC. , Scientists studying secondhand smoke ... exposure to harmful particles, with close-to-zero exposure to ... harmful metals in second-hand e-cigarette smoke were found ... contains high levels of polycyclic aromatic hydrocarbons ...
(Date:8/28/2014)... Ga. The support of peer groups and ... breastfeeding programs, according to recent University of Georgia ... in the Athens-Clarke County area determined that role ... outcomes of mothers of infants. , "Mothers who ... successful at breastfeeding," said study co-author Alex Anderson, ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Second-hand e-cig smoke compared to regular cigarette smoke 2Breastfeeding study shows need for effective peer counseling programs 2
... For clinicians, the ability to look routinely inside the body ... how it confronts disease is a distant dream. But in ... of researchers from the Howard Hughes Medical Institute (HHMI) at ... step toward realizing that vision by demonstrating the ability to ...
... insect forms—beetles, flies, dragonflies, mosquitoes, grasshoppers, ants, wasps, bees, ... all species known. The large number of insect species ... or more factors: a high rate of formation of ... new environments and exploit new ecological niches, and a ...
... No matter how healthy a life one leads, no person ... though the advances of the modern age may have extended ... genetic limits to longevity. One prominent theory of aging lays ... and proteins by “free radicals,?highly reactive molecules produced by the ...
Cached Biology News:Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method 2Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method 3Islands in the Genome Promote Speciation 2Navigating the brain for sense of direction as paradigm for higher cognitive functions 2
Automated Cell Culture Flask...
... high-throughput fluidics (HTF) system, 100-240 V, is ... array system that automates delivery of up ... the Bio-Plex array reader. The HTF system ... bulk sheath container to constantly maintain a ...
... laboratory, the revolutionary Luminex 100 System delivers ... in real time enhancing your operational efficiency. ... the Luminex 100, the XY Platform, and ... enables you to simultaneously assay up to ...
... This gradient system is ideal for routine binary ... highly sensitive Adept CE 4201 UV-Visible variable wavelength ... is provided by the two highly accurate ... CE 4100 solvent delivery pumps., Chromatograms may be ...
Biology Products: